GEN-MKT-18-7897-A
Feb 1, 2022 | Blogs, Cannabis, Food / Beverage, Food and Beverage | 0 comments
Read time: 2 minutes
As the new year commences and we make plans for 2022, cannabis will be a hot topic in some areas of the world. There may be continuations from 2021 around legislations and regulations, and we might even see new trends for some regions and countries.
Legalization of recreational cannabis in Germany
Let’s first discuss the news that is at the top of my list: legalization of cannabis for recreational use in Germany. In December 2021, Germany welcomed a new chancellor, Olaf Scholz, who has several plans on his agenda, including legalizing cannabis.1 Currently, it is not illegal to consume cannabis, but it is to buy it. This would make Germany the first major European country to legalize recreational marijuana.2
The parties in the new coalition government agreed to legalize the sale of cannabis to adults if it is sold in licensed establishments where it is properly taxed and quality controlled. Some believe this move will allow Germany to “have a regulated and taxed dispensary, controllable quality and effective youth protection through education.”2 However, some of the other parties are not in favor of this. For example, Markus Blume, the party secretary of the CSU, believes it will make a “harmful” drug into a “lifestyle product,” and according to a study, 59% of people say it would be better left the way it has been since 2011.2
Although we can’t say for certain that Olaf Scholz will implement this decision, it will be a hot topic in this year’s cannabis news, so watch for updates.
Cannabis in the US
For most of human history, until the early 20th century, cannabis use was legal in the US. Between 1916 and 1931, however, 29 US states banned the use of marijuana.3 Then came the Marihuana Tax Act of 1937, which was influenced by the Federal Bureau of Narcotics Commissioner at the time, Harry Anslinger and essentially made cannabis illegal across the US.4
When we look at the legislation in place today, we can see the legalization of cannabis has started to come full circle across the US. As of July 2021, cannabis had been legalized for recreational use in 18 states and approved for medical use in 37 states.5 Given this groundswell of support for medical and recreational cannabis use, might 2022 bring a federal move to legalization? Let’s take a look.
Back in September 2021, a key committee in the US House of Representatives approved a bill to federally legalize marijuana with an aim of promoting social equity.6 While federal cannabis legalization does not appear to be a priority for the Biden administration, efforts continue in the House and the US Senate to bring federal policy closer in line with state laws. With these efforts ongoing, and with 60% of adults believing that cannabis should be legal for both medical and recreational use 7, might 2022 be the year we see federal legalization?
References
RUO-MKT-18-14262-A
In monoclonal antibody (mAb) development, assessment of purity and integrity of the protein in question is critical. CE‑SDS is the gold standard assay and is routinely run from analytical development through QC and lot release. It’s trusted because it consistently delivers quantitative, size‑based insight into purity and fragmentation, and it fits naturally into regulated environments.
In drug discovery and development, Metabolite Identification (Met ID) plays a critical role in understanding biotransformation pathways, ensuring safety, and meeting regulatory requirements. Advanced mass spectrometry techniques have revolutionized this process, particularly through electron-based fragmentation methods such as Electron Activated Dissociation (EAD) and Electron Transfer Dissociation (ETD). While both techniques leverage electron interactions to generate informative fragment ions, they differ significantly in mechanism, performance, and suitability for Met ID workflows.
In analytical laboratories, performance is not optional. Whether supporting regulated pharmaceutical workflows, high-throughput CRO operations, clinical reporting, or food and environmental testing, your mass spectrometry and capillary electrophoresis systems are critical to productivity, compliance, and scientific confidence.
Posted by
You must be logged in to post a comment.
Share this post with your network